Alto Neuroscience

ANRONYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.202 B

$30.63 +1.19%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$63.2M

Loss-making

Shares outstanding

39,242,104

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#142HarrowHROW$1.27B
#143Opko HealthOPK$1.26B
#144Alto NeuroscienceANRO$1.20B
#145Aktis OncologyAKTS$1.19B
#146Seaport TherapeuticsSPTX$1.13B

What if Alto Neuroscience were worth as much as…

Open the what-if tool →

Gold $30.3T

$771,468.68

Per share 25,187× higher

Bitcoin $1.72T

$43,825.47

Per share 1,431× higher

Nvidia $5.48T

$139,642.31

Per share 4,559× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Alto Neuroscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.